ACRO Biomedical Co EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co is -92.89 M TWD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co changed from -64.15 M TWD to -92.89 M TWD, representing a 44.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ACRO Biomedical Co historically and in real time.